RAPIBLOC 300mg powder infusion solution medication leaflet

C07AB14 landiolol • Cardiovascular system | Beta blocking agents | Beta blocking agents, selective

Landiolol is a medication used to control supraventricular tachycardia and perioperative hypertension. It is an ultra-selective beta-blocker with rapid action that reduces heart rate and blood pressure by blocking beta-1 adrenergic receptors.

The medication is administered intravenously, usually in a hospital setting, under the supervision of a doctor. Due to its rapid onset and short duration of effect, it is ideal for use in acute situations.

Side effects may include low blood pressure, bradycardia, dizziness, or nausea. In rare cases, severe allergic reactions or heart failure may occur.

Patients should inform their doctor about any other medications they are taking and be closely monitored during treatment. Pregnant or breastfeeding women should consult a specialist before use.

General data about RAPIBLOC 300mg

Substance: landiolol

Date of last drug list: 01-06-2025

Commercial code: W66026001

Concentration: 300mg

Pharmaceutical form: powder infusion solution

Quantity: 1

Product type: original

Price: 1584.46 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: AOP ORPHAN PHARMACEUTICALS GMBH - AUSTRIA

Holder: AMOMED PHARMA GMBH - AUSTRIA

Number: 14034/2021/01

Shelf life: 3 years-after packing for marketing;after the first opening of the bottle-it is used immediately

Pharmaceutical forms available for landiolol

Concentrations available for landiolol

20mg/2ml, 300mg, 600mg